Literature DB >> 11994356

Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site.

Guadalupe Maya-Núñez1, Jo Ann Janovick, Alfredo Ulloa-Aguirre, Daniela Söderlund, P Michael Conn, Juan Pablo Méndez.   

Abstract

GnRH regulates the synthesis and release of pituitary gonadotropins. Mutations in the human GnRH receptor (hGnRHR) gene have been reported in families with hypogonadotropic hypogonadism. Our group recently described a novel homozygous E(90)K mutation of the hGnRHR in two siblings with the complete form of hypogonadotropic hypogonadism. In the present study, mutational analysis of the E(90)K substitution was performed to assess the functional role of this particular residue, which is located in the second transmembrane helix of the hGnRHR. Although E(90) is highly conserved in all other known mammalian GnRH receptors, this residue has not been previously implicated in GnRH binding and/or GnRHR activation. Transient expression of the mutant E(90)K receptor in COS-7 cells resulted in a virtual abolition of GnRH agonist binding and agonist-stimulated phosphoinositide turnover, initially suggesting that E(90) may be essential for GnRH binding. Furthermore, incubation with 1 microM of different GnRH agonists (D-Trp(6)-GnRH, GnRH, leuprolide, Catfish-1 GnRH, Catfish-2 GnRH, D-Lys(6)-Pro(9)-EA-GnRH, DesGly(10)-GnRH, D-Trp(6)-Pro(9)-EA-GnRH, Buserelin, and D-Lys(6)-GnRH) or antagonists (Antide and "Nal-Arg") did not result in elevated inositol phosphate production from cells expressing the E(90)K mutant. To examine the role of a site known to suppress hGnRHR function, mutants with deletion of K(191) (DeltaK(191)) from the hGnRHR and/or addition of catfish GnRHR intracellular carboxyl-terminal tail (cfCtail) to hGnRHR were prepared. Exposure to the GnRH analog Buserelin resulted in a significant increase in total inositol phosphate production in cells expressing the hGnRHR-cfCtail, hGnRHR(DeltaK(191)) and hGnRHR(DeltaK(191))-cfCtail. Activation of intracellular signaling in response to Buserelin was restored by deletion of K(191) from the E(90)K mutant receptor but minimally by addition of the catfish GnRHR carboxyl-terminal tail. There were no significant differences in total inositol phosphate production between the chimeric receptors bearing the DeltaK(191) or the E(90)K/DeltaK(191) modifications. All but the (E(90)K) and (E(90)K)-cfCtail altered receptors were membrane expressed as disclosed by Western blot analysis of epitope-tagged receptors. This study provides evidence that the E(90)K mutation impairs hGnRHR-effector coupling. The observation that sequence modifications that enhance surface expression of the receptor restore function, presents the possibility that loss of surface expression may underlie the severe phenotype exhibited by hypogonadotropic hypogonadism patients bearing this mutational defect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994356     DOI: 10.1210/jcem.87.5.8386

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

2.  Biochemical mechanism of pathogenesis of human gonadotropin-releasing hormone receptor mutants Thr104Ile and Tyr108Cys associated with familial hypogonadotropic hypogonadism.

Authors:  Guadalupe Maya-Núñez; Jo Ann Janovick; Arturo Aguilar-Rojas; Eduardo Jardón-Valadez; Alfredo Leaños-Miranda; Teresa Zariñan; Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2011-01-26       Impact factor: 4.102

3.  Rescue of misrouted GnRHR mutants reveals its constitutive activity.

Authors:  Jo Ann Janovick; Irina D Pogozheva; Henry I Mosberg; Anda Cornea; P Michael Conn
Journal:  Mol Endocrinol       Date:  2012-05-17

Review 4.  Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; James A Dias; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

Review 5.  Genotype and phenotype of patients with gonadotropin-releasing hormone receptor mutations.

Authors:  Hyung-Goo Kim; Jennifer Pedersen-White; Balasubramanian Bhagavath; Lawrence C Layman
Journal:  Front Horm Res       Date:  2010-04-08       Impact factor: 2.606

Review 6.  Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Adv Pharmacol       Date:  2011

Review 7.  Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Trends Endocrinol Metab       Date:  2009-12-11       Impact factor: 12.015

8.  Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor.

Authors:  Jo Ann Janovick; Akshay Patny; Ralph Mosley; Mark T Goulet; Michael D Altman; Thomas S Rush; Anda Cornea; P Michael Conn
Journal:  Mol Endocrinol       Date:  2008-12-18

9.  Mice harboring Gnrhr E90K, a mutation that causes protein misfolding and hypogonadotropic hypogonadism in humans, exhibit testis size reduction and ovulation failure.

Authors:  M David Stewart; Jian Ming Deng; C Allison Stewart; Rachael D Mullen; Ying Wang; Suhujey Lopez; M Katalina Serna; Cheng-Chiu Huang; Jo Ann Janovick; Andrew J Pask; Robert J Schwartz; P Michael Conn; Richard R Behringer
Journal:  Mol Endocrinol       Date:  2012-08-23

10.  Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression.

Authors:  Jo Ann Janovick; Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.